Estimating The Intrinsic Value Of Omnicell, Inc. (NASDAQ:OMCL)

Yahoo FinanceMay 25 07:07

Investors Aren't Buying Omnicell, Inc.'s (NASDAQ:OMCL) Revenues

With a price-to-sales (or "P/S") ratio of 1.3x Omnicell, Inc. (NASDAQ:OMCL) may be sending bullish signals at the moment, given that almost half of all the Medical Equipment companies in the United St

Simply Wall StMay 22 05:39

Analysts' Opinions Are Mixed on These Healthcare Stocks: Omnicell (OMCL), Tandem Diabetes Care (TNDM) and Amgen (AMGN)

TipRanksMay 22 04:20

Buy Rating on Omnicell Affirmed: Innovation and Growth Outlook Fuel Optimism for FY24 and Beyond

TipRanksMay 16 11:38

Omnicell | 10-Q: Quarterly report

SEC announcementMay 7 16:00 · Announcements

Omnicell Supports Global Charity Mercy Ships With Pharmacy Technology Donation

Omnicell, Inc. (NASDAQ:OMCL) ("Omnicell" or the "Company"), a leader in transforming the pharmacy care delivery model, today announced continued support for the global charity Mercy Ships with the donation of solutions

BusinesswireMay 6 15:23